NasdaqGS - Nasdaq Real Time Price USD
Allogene Therapeutics, Inc. (ALLO)
1.0401
+0.0873
+(9.16%)
As of 10:19:06 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BELLDEGRUN ARIE S Director | Stock Award(Grant) | Jan 24, 2025 | 11,009,100 |
| CHANG DAVID D M.D., PH.D. Chief Executive Officer | Sale | Mar 14, 2025 | 8,189,760 |
| DOUGLAS EARL MARTIN General Counsel | Sale | Feb 3, 2025 | 587,848 |
| HUMER FRANZ B Director | Sale | Dec 5, 2024 | 307,507 |
| MESSEMER DEBORAH M Director | Sale | Feb 18, 2025 | 144,316 |
| MOORE TIMOTHY L. Chief Technology Officer | Sale | Feb 3, 2025 | 250,713 |
| PARKER GEOFFREY M Chief Financial Officer | Sale | Feb 3, 2025 | 1,301,540 |
| ROBERTS ZACHARY Officer | Sale | Feb 3, 2025 | 643,135 |
| SATO VICKI LEE Director | Stock Award(Grant) | Jun 5, 2024 | 162,575 |
| YOSHIYAMA ANNIE Officer | Sale | Apr 21, 2025 | 130,663 |
Related Tickers
FATE Fate Therapeutics, Inc.
0.9553
-0.49%
CRBU Caribou Biosciences, Inc.
0.7709
-5.86%
EDIT Editas Medicine, Inc.
1.3650
-1.09%
AUTL Autolus Therapeutics plc
1.2150
-0.41%
SGMO Sangamo Therapeutics, Inc.
0.4202
-4.06%
IOVA Iovance Biotherapeutics, Inc.
1.6750
-1.76%
VERV Verve Therapeutics, Inc.
4.1350
-4.06%
AVXL Anavex Life Sciences Corp.
8.07
-1.29%
SANA Sana Biotechnology, Inc.
1.6695
-6.21%
ALXO ALX Oncology Holdings Inc.
0.4449
-3.16%